A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Vasa deferentia taken from mice treated with Delta(9)-tetrahydrocannabinol (20 mg/kg i.p., once daily for 2 days) showed tolerance to the inhibitory effect of the cannabinoid, R-(+)-arachidonyl-1'-hydroxy-2'-propylamide, on electrically evoked twitches. This treatment did not induce tolerance to the inhibitory effects on the twitch response of morphine or clonidine or of selective mu-, delta- or kappa-opioid receptor agonists. Nor did it affect the contractile potencies of noradrenaline or beta,gamma-methylene-L-ATP. We suggest that cannabinoid tolerance in the vas deferens is attributable neither to downregulation of opioid receptors or alpha(2)-adrenoceptors nor to an increased sensitivity of this tissue to its main contractile transmitters noradrenaline and ATP. A concentration of Delta(9)-tetrahydrocannabinol that inhibits electrically evoked twitches of the vas deferens (100 nM) did not alter the ability of noradrenaline or beta,gamma-methylene-L-ATP to induce contractions suggesting that Delta(9)-tetrahydrocannabinol inhibits the twitch response by acting prejunctionally.

Original languageEnglish
Pages (from-to)67-72
Number of pages6
JournalEuropean Journal of Pharmacology
Volume272
Issue number1
DOIs
Publication statusPublished - 5 Jan 1995

Keywords

  • CANNABINOID
  • OPIOID
  • NORADRENALINE
  • BETA,GAMMA-METHYLENE-L-ATP
  • VAS DEFERENS, MOUSE
  • TOLERANCE
  • ADENOSINE 5'-TRIPHOSPHATE
  • SYMPATHETIC-NERVES
  • RECEPTOR-BINDING
  • GUINEA-PIG
  • DELTA-9-TETRAHYDROCANNABINOL
  • MORPHINE
  • BRAIN
  • cannabinoid
  • opioid
  • noradrenaline
  • ß,¿-Methylene- -ATP
  • Vas deferens mouse
  • tolerance

Cite this

A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens . / Pertwee, Roger Guy; Griffin, G .

In: European Journal of Pharmacology, Vol. 272, No. 1, 05.01.1995, p. 67-72.

Research output: Contribution to journalArticle

@article{1205a947a1c14c68906abb216ffc13f8,
title = "A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens",
abstract = "Vasa deferentia taken from mice treated with Delta(9)-tetrahydrocannabinol (20 mg/kg i.p., once daily for 2 days) showed tolerance to the inhibitory effect of the cannabinoid, R-(+)-arachidonyl-1'-hydroxy-2'-propylamide, on electrically evoked twitches. This treatment did not induce tolerance to the inhibitory effects on the twitch response of morphine or clonidine or of selective mu-, delta- or kappa-opioid receptor agonists. Nor did it affect the contractile potencies of noradrenaline or beta,gamma-methylene-L-ATP. We suggest that cannabinoid tolerance in the vas deferens is attributable neither to downregulation of opioid receptors or alpha(2)-adrenoceptors nor to an increased sensitivity of this tissue to its main contractile transmitters noradrenaline and ATP. A concentration of Delta(9)-tetrahydrocannabinol that inhibits electrically evoked twitches of the vas deferens (100 nM) did not alter the ability of noradrenaline or beta,gamma-methylene-L-ATP to induce contractions suggesting that Delta(9)-tetrahydrocannabinol inhibits the twitch response by acting prejunctionally.",
keywords = "CANNABINOID, OPIOID, NORADRENALINE, BETA,GAMMA-METHYLENE-L-ATP, VAS DEFERENS, MOUSE, TOLERANCE, ADENOSINE 5'-TRIPHOSPHATE, SYMPATHETIC-NERVES, RECEPTOR-BINDING, GUINEA-PIG, DELTA-9-TETRAHYDROCANNABINOL, MORPHINE, BRAIN, cannabinoid, opioid, noradrenaline, {\ss},¿-Methylene- -ATP, Vas deferens mouse, tolerance",
author = "Pertwee, {Roger Guy} and G Griffin",
year = "1995",
month = "1",
day = "5",
doi = "10.1016/0014-2999(94)00617-G",
language = "English",
volume = "272",
pages = "67--72",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

AU - Pertwee, Roger Guy

AU - Griffin, G

PY - 1995/1/5

Y1 - 1995/1/5

N2 - Vasa deferentia taken from mice treated with Delta(9)-tetrahydrocannabinol (20 mg/kg i.p., once daily for 2 days) showed tolerance to the inhibitory effect of the cannabinoid, R-(+)-arachidonyl-1'-hydroxy-2'-propylamide, on electrically evoked twitches. This treatment did not induce tolerance to the inhibitory effects on the twitch response of morphine or clonidine or of selective mu-, delta- or kappa-opioid receptor agonists. Nor did it affect the contractile potencies of noradrenaline or beta,gamma-methylene-L-ATP. We suggest that cannabinoid tolerance in the vas deferens is attributable neither to downregulation of opioid receptors or alpha(2)-adrenoceptors nor to an increased sensitivity of this tissue to its main contractile transmitters noradrenaline and ATP. A concentration of Delta(9)-tetrahydrocannabinol that inhibits electrically evoked twitches of the vas deferens (100 nM) did not alter the ability of noradrenaline or beta,gamma-methylene-L-ATP to induce contractions suggesting that Delta(9)-tetrahydrocannabinol inhibits the twitch response by acting prejunctionally.

AB - Vasa deferentia taken from mice treated with Delta(9)-tetrahydrocannabinol (20 mg/kg i.p., once daily for 2 days) showed tolerance to the inhibitory effect of the cannabinoid, R-(+)-arachidonyl-1'-hydroxy-2'-propylamide, on electrically evoked twitches. This treatment did not induce tolerance to the inhibitory effects on the twitch response of morphine or clonidine or of selective mu-, delta- or kappa-opioid receptor agonists. Nor did it affect the contractile potencies of noradrenaline or beta,gamma-methylene-L-ATP. We suggest that cannabinoid tolerance in the vas deferens is attributable neither to downregulation of opioid receptors or alpha(2)-adrenoceptors nor to an increased sensitivity of this tissue to its main contractile transmitters noradrenaline and ATP. A concentration of Delta(9)-tetrahydrocannabinol that inhibits electrically evoked twitches of the vas deferens (100 nM) did not alter the ability of noradrenaline or beta,gamma-methylene-L-ATP to induce contractions suggesting that Delta(9)-tetrahydrocannabinol inhibits the twitch response by acting prejunctionally.

KW - CANNABINOID

KW - OPIOID

KW - NORADRENALINE

KW - BETA,GAMMA-METHYLENE-L-ATP

KW - VAS DEFERENS, MOUSE

KW - TOLERANCE

KW - ADENOSINE 5'-TRIPHOSPHATE

KW - SYMPATHETIC-NERVES

KW - RECEPTOR-BINDING

KW - GUINEA-PIG

KW - DELTA-9-TETRAHYDROCANNABINOL

KW - MORPHINE

KW - BRAIN

KW - cannabinoid

KW - opioid

KW - noradrenaline

KW - ß,¿-Methylene- -ATP

KW - Vas deferens mouse

KW - tolerance

U2 - 10.1016/0014-2999(94)00617-G

DO - 10.1016/0014-2999(94)00617-G

M3 - Article

VL - 272

SP - 67

EP - 72

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -